PBSCT

PROCEDURE2 trials

Sponsors

H. Lee Moffitt Cancer Center and Research Institute, University of Nebraska

Conditions

LymphomaMultiple MyelomaPlasma Cell Leukemia

Phase 2

Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants

CompletedNCT00307086

H. Lee Moffitt Cancer Center and Research InstituteMultiple Myeloma, Plasma Cell Leukemia

Start: 2005-06-30End: 2012-03-31Updated: 2017-03-06

Unknown Phase

Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma

CompletedNCT00574626

University of NebraskaLymphoma

Start: 1991-12-12End: 2010-05-05Updated: 2023-12-28